The main achievements have been the launch of a breast cancer early detection programme, the construction of two centres of excellence dedicated to the management of gynaecological and breast cancers, the establishment of a programme for vulnerable and indigent patients to access innovative drugs, including anti-Her2 therapies. Here, ERBB2 is linked to breast carcinoma.